FDA 483 - Amneal Complex Products Research LLC - April 18, 2018

An FDA inspection of Kasiya Pharma, LLC in Bridgewater, NJ, revealed two significant issues. The firm failed to thoroughly review out-of-specification (OOS) investigations, specifically regarding unknown peaks in samples, and lacked written procedures for its quality control unit's responsibilities, including AQL inspections.